# FDA Inspection 1283114 - Solaris Pharma Corp - September 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/21c2d32d-4377-4be5-8382-b321a855a9ae
Source feed: FDA_Inspections

> FDA Inspection 1283114 for Solaris Pharma Corp on September 18, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1283114
- Company Name: Solaris Pharma Corp
- Inspection Date: 2025-09-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1283114 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/a78a33e0-bed5-43f4-8243-b3dddf80fd56)
- [FDA Inspection 1117923 - 2020-01-09](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/84366ff4-2f07-49eb-89c5-e3009928fbd2)

Company: https://www.keypedia.com/companies/solaris-pharma-corp/2730f83a-223f-4ef6-95e1-4e3b069342ce

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248